We serve Chemical Name:7-[4-[4-(4-fluorobenzoyl)piperidin-1-yl]butyl]-1,3-dimethylpurine-2,6-dione CAS:110390-84-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:7-[4-[4-(4-fluorobenzoyl)piperidin-1-yl]butyl]-1,3-dimethylpurine-2,6-dione
CAS.NO:110390-84-6
Synonyms:Perbufylline [INN];UNII-M69H5TDQ1K;7-(4-(4-(p-Fluorobenzoyl)piperidino)butyl)theophylline;Perbufylline
Molecular Formula:C23H28FN5O3
Molecular Weight:441.49900
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:647.3ºC at 760mmHg
Density:1.34g/cm3
Index of Refraction:1.644
PSA:82.13000
Exact Mass:441.21800
LogP:1.88580
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Perbufylline [INN] chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Perbufylline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,7-(4-(4-(p-Fluorobenzoyl)piperidino)butyl)theophylline Use and application,Perbufylline [INN] technical grade,usp/ep/jp grade.
Related News: As United Airlines said when suspended flights to Beijing, Shanghai and Chengdu, the decision was made due to the continued drop in demand for travel to China and the US Department of State��s decision to raise its China travel advisory to a Level 4. 7-[4-[4-(4-fluorobenzoyl)piperidin-1-yl]butyl]-1,3-dimethylpurine-2,6-dione manufacturer Further research on Oligomannate��s pharmacological mechanism and long-term safety and effectiveness is required, according to the NMPA statement. 7-[4-[4-(4-fluorobenzoyl)piperidin-1-yl]butyl]-1,3-dimethylpurine-2,6-dione supplier Further research on Oligomannate��s pharmacological mechanism and long-term safety and effectiveness is required, according to the NMPA statement. 7-[4-[4-(4-fluorobenzoyl)piperidin-1-yl]butyl]-1,3-dimethylpurine-2,6-dione vendor The unit of the British drugmaker, which is challenging HIV drug market leader Gilead Sciences, said it will work with the FDA to determine the next steps for the new drug application. 7-[4-[4-(4-fluorobenzoyl)piperidin-1-yl]butyl]-1,3-dimethylpurine-2,6-dione factory The unit of the British drugmaker, which is challenging HIV drug market leader Gilead Sciences, said it will work with the FDA to determine the next steps for the new drug application.